Results 91 to 100 of about 482,170 (194)

Pathogenesis, management, and prevention of recurrent pericarditis

open access: yes, 2007
Recurrent pericarditis is one of the most troublesome complications of acute pericarditis and, despite recent advances, remains one of the most challenging problems in pericardial diseases.
Shabetai R, Imazio M, Trinchero R
core  

Multiyear Recurrent Pericarditis Disease Duration: Clinical Outcomes After Cessation of Long‐Term Interleukin‐1 Pathway Inhibition Provide Insights for Chronic Management

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Recurrent pericarditis is an interleukin‐1–mediated chronic autoinflammatory disease. The phase 3 study RHAPSODY (Rilonacept Inhibition of IL‐1 Alpha and IL‐1 Beta for Recurrent Pericarditis: a Pivotal Symptomatology and Outcomes Study ...
Lucia Trotta   +11 more
doaj   +1 more source

Aetiological diagnosis in acute and recurrent pericarditis: When and how

open access: yes, 2009
The cause of acute and recurrent pericarditis is often a major concern for the clinicians in clinical practice. Several possible causes of pericarditis can be listed, as the pericardium may be involved in a large number of systemic disorders or may be ...
DeRosa F. G.   +31 more
core   +1 more source

MORPHOLOGICAL FEATURES OF CONSTRICTIVE PERICARDITIS

open access: yesРоссийский кардиологический журнал, 2010
The features of pericardial morphology in constrictive pericarditis are described, based on the surgery material, which was obtained from 27 patients aged 5-77 years during pericardectomy.
V. V. Kochmasheva   +2 more
doaj  

Early Introduction and Prolonged Full‐Dose Anakinra Reduce Recurrence Risk After Discontinuation in Recurrent Pericarditis: An International Multicenter Cohort

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Anakinra is effective in recurrent pericarditis, yet optimal treatment duration and strategies for safe drug discontinuation remain uncertain.
Danilo Malandrino   +27 more
doaj   +1 more source

Unraveling Heart Inflammation: Recurrent Myopericarditis Caused by Coxsackie A Virus—A Case Report

open access: yesClinical Case Reports
Acute recurrent myopericarditis, characterized by the occurrence of a new myopericarditis event following a symptom‐free interval of 4–6 weeks, is relatively rare lacking definitive guidelines for management.
Maisha Maliha   +8 more
doaj   +1 more source

Role of Cardiac MRI and CT in Pericarditis and Pericardial Constriction

open access: yesMethodist DeBakey Cardiovascular Journal
Pericardial diseases span a spectrum from acute and recurrent pericarditis to chronic constrictive pericarditis. While echocardiography remains the first-line test in the evaluation of patients with suspected pericardial disease, advanced cardiac imaging
Kazim Baser   +6 more
doaj   +1 more source

Recurrent pericarditis: the importance of guideline-based treatment for reducing recurrences. A single centre experience.

open access: yes
reservedIntroduction: Acute pericarditis, while generally considered a benign disease, may relapse in a sizable proportion of cases. Although innovative therapies, such as anti-IL1 drugs, have emerged as promising treatment options, the criteria for ...
BOCAJ, IRIS
core  

P118 | Long term outcome and disease duration in patients treated with anti-IL 1 drugs for recurrent pericarditis: ad interim analysis of a longitudinal study

open access: yesItalian Journal of Medicine
Background: Although anti-IL 1 drugs have been proven effective in treating recurrent pericarditis, there is a lack of data about their long-term follow-up. Objectives: To evaluate the percentage of patients with recurrent pericarditis treated with anti-
doaj   +1 more source

Sustained Pericarditis Recurrence Risk Reduction With Long‐Term Rilonacept

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Rilonacept, a once‐weekly interleukin‐1 alpha and beta cytokine trap, reduced pericarditis recurrence in the phase 3 study, RHAPSODY (Rilonacept Inhibition of Interleukin‐1 Alpha and Beta for Recurrent Pericarditis: A Pivotal Symptomatology ...
Massimo Imazio   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy